Gilead Sciences Inc (NASDAQ:GILD)

74.44
Delayed Data
As of Apr 19
 -1.24 / -1.64%
Today’s Change
63.76
Today|||52-Week Range
89.54
+3.91%
Year-to-Date

Today’s Trading

Previous close75.68
Today’s open75.42
Day’s range73.83 - 75.92
Volume3,958,155
Average volume (3 months)8,038,661
Market cap$105.7B
Data as of 4:00pm ET, 04/19/2018

Growth & Valuation

Earnings growth (last year)-64.69%
Earnings growth (this year)-27.12%
Earnings growth (next 5 years)-3.25%
Revenue growth (last year)-13.79%
P/E ratio21.2
Price/Sales3.62
Price/Book5.16

Competitors

 Today’s
change
Today’s
% change
AMGNAmgen-2.18-1.24%
BIIBBiogen-2.01-0.75%
ILMNIllumina Inc-4.16-1.66%
----
Data as of 4:00pm ET, 04/19/2018

Financials

Next reporting dateMay 2, 2018
EPS forecast (this quarter)$1.69
Annual revenue (last year)$26.1B
Annual profit (last year)$4.6B
Net profit margin17.71%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John F. Milligan
CFO, Principal Accounting Officer &
Executive VP
Robin L. Washington
Corporate headquarters
Foster City, California

Forecasts